AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
132.86B
ATGRX
Price
$13.95
Change
+$0.06 (+0.43%)
Updated
Sep 5 closing price
Net Assets
2.63B
Interact to see
Advertisement

AEPCX vs ATGRX

Header iconAEPCX vs ATGRX Comparison
Open Charts AEPCX vs ATGRXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets132.86B
American Century International Gr R
Price$13.95
Change+$0.06 (+0.43%)
VolumeN/A
Net Assets2.63B
AEPCX vs ATGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. ATGRX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and ATGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. ATGRX (2.63B). AEPCX pays higher dividends than ATGRX: AEPCX (0.16) vs ATGRX (0.09). AEPCX was incepted earlier than ATGRX: AEPCX (24 years) vs ATGRX (22 years). ATGRX (1.72) is less costly to investors than AEPCX (1.57). ATGRX is a more actively managed with annual turnover of: 56.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than ATGRX: AEPCX (250) vs ATGRX (2500). AEPCX annual gain was more profitable for investors over the last year : 7.59 vs. ATGRX (5.73). AEPCX return over 5 years is better than : 7.78 vs. ATGRX (-1.18).
AEPCXATGRXAEPCX / ATGRX
Total Expense Ratio1.571.7291%
Annual Report Gross Expense Ratio1.571.7291%
Fund Existence24 years22 years-
Gain YTD15.03811.746128%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets133B2.63B5,063%
Annual Yield % from dividends0.160.09178%
Returns for 1 year7.595.73132%
Returns for 3 years32.6534.8694%
Returns for 5 years7.78-1.18-661%
Returns for 10 years34.3416.06214%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIVSX18.86N/A
N/A
River Oak Discovery
TADFX8.47N/A
N/A
Transamerica Sustainable Equity Inc R6
PNRAX58.29N/A
N/A
Putnam Research A
LGOAX45.89N/A
N/A
Patient Opportunity A
ITCSX26.54N/A
N/A
VY® T. Rowe Price Capital Apprec S